• Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments | Morningstar

    Источник: Buzz FX / 08 ноя 2024 08:31:27   America/New_York


    Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments In-licensed ALXN-1840 (a Late-Stage Wilson Disease Drug Candidate) from Alexion, AstraZeneca Rare Disease Two Novel Radiopharma Clinical Trials now Ac
    Read more...
Опубликовать